글로벌 모체 혈액 검사 시장 – 2030년까지의 산업 동향 및 예측

모체 혈액 검사 시장 분석 및 규모

모체 혈액 검사 시장 성장을 주도하는 주요 요인 중 하나는 전 세계적으로 NIPT에 대한 보상 시나리오의 지속적인 개선입니다. 염색체 이상 발생률의 증가와 새로운 응용 분야에서의 제품 사용 증가가 결합되어 시장 성장을 주도합니다. 침습적 방법보다 비침습적 기술에 대한 선호도가 높아지고 NIPT에 대한 인식을 높이기 위한 프로그램이 늘어나는 것은 모두 시장에 영향을 미칩니다.

Data Bridge Market Research는 2022년에 38억 7천만 달러였던 모체 혈액 검사 시장이 2030년까지 101억 2천만 달러에 도달할 것으로 분석했으며, 2023년부터 2030년까지의 예측 기간 동안 13.00%의 CAGR을 기록할 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

모체 혈액 검사 시장 범위 및 세분화  

시장 정의

A maternal blood test is a type of prenatal screening test that determines the likelihood that a chromosome disorder will impact a pregnancy or certain behavioural issues will impact a pregnancy. The primary goal of the test is to ensure that the baby does not have any chromosomal abnormalities such as Down syndrome. These tests are known to be capable of providing more information about pregnancy health.

Global Maternal Blood Test Market Dynamics

Drivers

• Rising use of maternal blood tests

Maternal blood tests can detect and diagnose chromosomal rearrangements, X-linked diseases, and aid in the reduction of spontaneous abortions, increased implantation rates, the prevention of trisomic offspring, and the avoidance of the risk of transmitting single gene disorders. However, PGS and PGD results are not 100% accurate, and if necessary, diagnostic tests such as amniocentesis and CVS must be performed after pregnancy to confirm the positive PGS/PGD results. In the United States alone, more than 63,000 babies were born through IVF in 2013, an increase of 2,000 births from 2012. These are the certain test that help the market to grow.

Opportunities

• Introduction of NIPTs

The introduction of NIPTs using cell-free foetal DNA (cffDNA) in 2011 was the most significant advancement in the field of prenatal screening. Obstetricians and patients who are put off by ultrasound screening's 10% to 15% false positive rate and maternal serum test's 5% false positive rate are eagerly embracing NIPTs that claim to have only a 5% false positive rate. In just four years, molecular genetics companies have successfully developed eight different types of kits for detecting genetic abnormalities in foetus. These products have gradually marginalized maternal serum tests, and maternal serum tests are expected to become obsolete within the next decade.

Restraints/Challenges

• Lack of skilled professionals

Lack of skilled and trained professionals, strict regulatory guidelines and ethical stumbling blocks limits the market's growth during the forecast period.

This maternal blood test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the maternal blood test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Maternal Blood Test Market Scope

The maternal blood test market is segmented on the basis of type, tested condition and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Combined First Trimester Screening
• Second Trimester Maternal Serum Screening

 Tested Conditions

• Edwards Syndrome
• Patau Syndrome
• Down syndrome
• Neural Tube Defects

End-User

• Diagnostic Laboratories
• Hospitals

Maternal Blood Test Market Regional Analysis/Insights

The maternal blood test market is analyzed and market size insights and trends are provided by country, type, tested condition and end-user as referenced above.

The countries covered in the maternal blood test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the maternal blood test market because of the high adoption of advanced technologies within the region. 

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the developing healthcare infrastructure, and increasing awareness programs and conferences in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The maternal blood test market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for maternal blood test market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the maternal blood test market. The data is available for historic period 2011-2021.

Competitive Landscape and Maternal Blood Test Market Share Analysis

모체 혈액 검사 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우위가 있습니다. 위에 제공된 데이터 포인트는 모체 혈액 검사 시장과 관련된 회사의 초점에만 관련이 있습니다.

산모 혈액 검사 시장에서 활동하는 주요 업체는 다음과 같습니다.

• 센토진 NV(독일)
• 시퀀놈(미국)
• 나테라 주식회사(미국)
• LifeLabs Genetics(캐나다)
• 세마4 옵코 주식회사(미국)
• 인비테 코퍼레이션(미국)
• 일루미나 주식회사(미국)
• Thermo Fisher Scientific Inc. (미국)
• 제너럴 일렉트릭(미국)
• 퍼킨엘머 주식회사(미국)
• Agilent Technologies, Inc. (미국)
• BGI(중국)
• F. 호프만-라 로슈 유한회사(스위스)
• YOURGENE HEALTH(영국)
• Eurofins Scientific(룩셈부르크)
• EKF 진단(독일)

SKU-47812